Literature DB >> 30972790

Risk factors and outcomes for neonatal hypoglycaemia and neonatal hyperbilirubinaemia in pregnancies complicated by gestational diabetes mellitus: a single centre retrospective 3-year review.

A Thevarajah1, D Simmons1,2.   

Abstract

AIM: To determine risk factors associated with neonatal hypoglycaemia and hyperbilirubinaemia, and assess their impact on neonatal outcomes in pregnancies complicated by gestational diabetes mellitus (GDM).
METHODS: Retrospective review investigating all pregnancies complicated by GDM at Campbelltown Hospital (Sydney, Australia) between 1 January 2013 and 31 December 2015. Main outcomes measured were neonatal hypoglycaemia (capillary glucose levels < 1.8 mmol/l) and hyperbilirubinaemia (total serum bilirubin levels greater than age-appropriate thresholds for phototherapy). Adjusted odds ratios [95% confidence interval (CI)] are shown, calculated by multivariable logistic regression.
RESULTS: Some 60 (7.8%) infants developed hypoglycaemia, 58 (7.5%) developed hyperbilirubinaemia and 13 (1.7%) developed both. Risk of developing hypoglycaemia increased 1.8-fold (95% CI 1.3-2.6, P < 0.001) per gestational week at GDM diagnosis, 1.1-fold (95% CI 1.0-1.3, P = 0.04) per mmol/l maternal fasting glucose, 6.2-fold (95% CI 2.6-16.2, P < 0.001) with maternal history of macrosomia, 10.8-fold (95% CI 4.1-27.6, P < 0.001) with multiple pregnancy and 1.1-fold (95% CI 1.0-1.3, P = 0.04) per gestational week at birth. Risk of hyperbilirubinaemia increased with multiple pregnancy (26.4; 95% CI 11.7-59.7, P < 0.001), and 1.5-fold (95% CI 1.1-2.1, P = 0.01) per gestational week at GDM diagnosis. Hypoglycaemia was associated with a 2.8-fold (95% CI 1.1-7.1, P = 0.03) increased risk of macrosomia, a 5.4-fold (95% CI 1.1-27.3, P = 0.04) excess risk of shoulder dystocia and a 6.4-fold increased risk of 5-min APGAR ≤ 7 (95% CI 1.2-1.7, P < 0.001). Hyperbilirubinaemia was associated with an excess risk of polycythaemia (packed cell volume > 0.6; 97.1, 95% CI 38.9-241.5, P < 0.001).
CONCLUSIONS: Neonatal hypoglycaemia and hyperbilirubinaemia largely occur in different pregnancies. Both are associated with earlier GDM diagnosis; however, hypoglycaemia is more associated with maternal glycaemia and its sequelae, and hyperbilirubinaemia is associated with polycythaemia.
© 2019 Diabetes UK.

Entities:  

Mesh:

Year:  2019        PMID: 30972790     DOI: 10.1111/dme.13962

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  7 in total

1.  [Risk factors for hypoglycemia in preterm infants with a gestational age of ≤32 weeks].

Authors:  Zhi-Xuan Yuan; Hui Gao; Can-Can Duan; Yang Wang; Li-Li Wang
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2020-11

2.  Differential effects of delayed cord clamping on bilirubin levels in normal and diabetic pregnancies.

Authors:  Shuangjia Pan; Qiujing Lu; Yehui Lan; Lingli Peng; Xiaohong Yu; Ying Hua
Journal:  Eur J Pediatr       Date:  2022-06-25       Impact factor: 3.860

3.  Risk of hypoglycemia by anthropometric measurements in neonates of mothers with diabetes.

Authors:  Hanane Bouchghoul; Delphine Mitanchez Mokhtari; Alexandra Letourneau; Jean Bouyer; Marie-Victoire Senat
Journal:  Eur J Pediatr       Date:  2022-07-04       Impact factor: 3.860

4.  Development and evaluation of an online questionnaire to identify women at high and low risk of developing gestational diabetes mellitus.

Authors:  Daria Di Filippo; Chloe Bell; Melissa Han Yiin Chang; Justine Darling; Amanda Henry; Alec Welsh
Journal:  BMC Pregnancy Childbirth       Date:  2022-04-14       Impact factor: 3.105

5.  Association between neonatal hyperbilirubinemia and hypoglycemia in Chinese women with diabetes in pregnancy and influence factors.

Authors:  Jing He; Jiayang Song; Zhijie Zou; Xiaoxiao Fan; Ruixue Tian; Jingqi Xu; Yu Yan; Jinbing Bai; Zhen Chen; Yanqun Liu; Xiaoli Chen
Journal:  Sci Rep       Date:  2022-10-10       Impact factor: 4.996

6.  Metformin: A promising option for the management of gestational diabetes mellitus - Exploring the benefits, challenges and clinical needs in the current management of gestational diabetes mellitus.

Authors:  Beenu Bastian; Lisa Gaye Smithers; Warren Davis; Alexia Pape; Monique E Francois
Journal:  Aust N Z J Obstet Gynaecol       Date:  2022-04-01       Impact factor: 1.884

7.  The risk of morbidities in newborns of antenatal vitamin D supplemented gestational diabetes mellitus patients.

Authors:  Sumanta Saha; Sujata Saha
Journal:  Int J Health Sci (Qassim)       Date:  2020 Sep-Oct
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.